Table 5 Potential risk assessment of medication discrepancies by Bayliff tool
Risk classification | N | % |
|---|---|---|
Level 0: No clinical impact | 0 | 0 |
Level 1: mild potential clinical impact | 90 | 17.8 |
Level 2: potential clinical impact leading to further treatment or lengthened hospital stay | 364 | 71.9 |
Level 3: Life-threatening | 52 | 10.3 |